ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT06901531 updates: 1. completion date: 2028-09-30 → 2027-03-31 2. primary completion date: 2028-09-30 → 2027-03-31
Clinical trial NCT06901531 updates: 1. completion date: 2028-09-30 → 2027-03-31 2. primary completion date: 2028-09-30 → 2027-03-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical